The National Cardiovascular Data Registry (NCDR®) CathPCI Registry® is an "excellent" disease registry according to a recent report that analyzed "progress toward value-based health care." The report, released by The Boston Consulting Group, provides insight into the lessons that 12 countries across the globe have learned while implementing value-based systems that maintain or reduce costs while improving health outcomes. "Value-based health care is becoming the focus of many health-care-reform efforts around the world because it promises to be a more effective and more sustainable approach for limiting the increase in health care costs than traditional approaches such as utilization reviews or cost controls," explains the report.
The report takes a look at best practices that are emerging across the globe, including the development of comprehensive disease registries. In addition to the CathPCI Registry, the Cystic Fibrosis Foundation Patient Registry and the Society for Thoracic Surgeons’ STS National Database are also highlighted as examples of successful registries in the U.S. While some countries have made significant progress on the path to value-based systems, others are lagging behind. It appears that numerous countries have one or several excellent registries, but there is a lack of consistency across conditions and regions. In the U.S., the "complexity" and "fragmentation" of the health care system has hindered the application of a value-based system nationwide. According to the authors, "For many countries, the next big challenge—and opportunity—is to expand value-based initiatives to the national level."
The CathPCI Registry provides a comprehensive, nationwide picture of cardiac catheterization and percutaneous coronary intervention (PCI) procedures that helps identify quality gaps and implement new processes to improve patient care. While some countries that were analyzed had impressive data infrastructure in place, outcomes were not always improved. The CathPCI Registry is effective in reducing door-to-balloon times, decreasing vascular groin complications, and increasing guideline compliance. The registry produces risk-adjusted benchmark reports containing practice patterns, demographics, and outcomes of diagnostic procedures and therapies, showing a facility, comparable facilities, and the national comparison group data. The registry also offers a unique view of guidelines in practice, PCI records tracking pharmaceutical and device safety, plus research findings from peer-reviewed journal articles and abstracts.
The suite of NCDR registries covers acute coronary syndrome; pediatric and adult congenital treatment; artery revascularization and endarterectomy procedures; implantable cardioverter defibrillators and leads; transcatheter valve therapy procedures; and coronary artery disease, hypertension, heart failure and atrial fibrillation in the outpatient setting.
To learn more about the NCDR including the CathPCI Registry, visit www.ncdr.com.